Leaflet ALVESCO 40 INHALER 40mcg / dose pressurized inhalation solution


Indicated for: asthma; allergic rhinitis

Substance: ciclesonide (bronchodilator)

ATC: R03BA08 (Respiratory system | Other drugs for obstructive airway diseases, inhalants | Glucocorticoids)

Ciclesonide is a glucocorticoid used for the treatment of asthma and allergic rhinitis. It works by reducing inflammation in the airways, alleviating symptoms such as breathing difficulties and nasal congestion.

The medication is administered as an inhaler or nasal spray, as directed by a doctor. It is important for patients to use the medication regularly to achieve maximum benefits.

Patients should be aware of potential side effects, such as throat irritation, hoarseness, or nasal dryness. It is important to inform the doctor of any unusual symptoms.

Common side effects include throat irritation, hoarseness, and nasal dryness. In rare cases, severe reactions such as oral fungal infections or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about ALVESCO 40 INHALER 40mcg / dose

  • Substance: ciclesonide
  • Date of last drug list: 01-07-2013
  • Commercial code: W42760002
  • Concentration: 40mcg / dose
  • Pharmaceutical form: pressurized inhalation solution
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for ciclesonide

  • 160mcg/dose
  • 40mcg/dose
  • 80mcg/dose